Cargando…
阿伐曲泊帕转换治疗TPO受体激动剂难治性再生障碍性贫血疗效及安全性
OBJECTIVE: Short-term efficacy and safety of afatrombopag conversion therapy in patients with aplastic anemia（AA）who were previously ineffectively treated with intense immunosuppressive therapy（IST）combined with TPO receptor Agonist（TPO-RA）or who were unable to tolerate the side effects of TPO-RA. M...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Editorial office of Chinese Journal of Hematology
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9808864/ https://www.ncbi.nlm.nih.gov/pubmed/36709183 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2022.11.007 |